[Myeloma and myelomonocytic leukemia. Role of melphalan. Ultrastructural and cytoenzymologic study].
D000328:Adult; D000368:Aged; D004950:Esterases / Q000378:metabolism; D005260:Female; D006651:Histocytochemistry; D006801:Humans; D007165:Immunosuppression Therapy; D007951:Leukemia, Myeloid / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D008297:Male; D008558:Melphalan / Q000009:adverse effects* / Q000627:therapeutic use*; D008854:Microscopy, Electron; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D009194:Myeloma Proteins / Q000032:analysis; D010544:Peroxidases / Q000378:metabolism; D010950:Plasma Cells / Q000201:enzymology
D009194:Myeloma Proteins; D010544:Peroxidases; D004950:Esterases; D008558:Melphalan
Myelome et leucose myelomonocytaire. Rôle du melphalan. Etude ultrastructurale et cytoenzymologique.